Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2024 Jun 21:2024.06.09.24308673.
doi: 10.1101/2024.06.09.24308673.

Seroprevalence of SARS-CoV-2 and risk factors for infection among children in Uganda: a serial cross-sectional study

Irene Bagala  1   2 , Jane Frances Namuganga  2 , Patience Nayebare  2 , Gloria Cuu  2 , Thomas Katairo  2 , Isaiah Nabende  2 , Samuel Gonahasa  2 , Martha Nassali  2 , Stephen Tukwasibwe  2 , Grant Dorsey  3 , Joaniter Nankabirwa  1   2 , Sabrina Bakeera Kitaka  1 , Sarah Kiguli  1 , Bryan Greenhouse  3 , Isaac Ssewanyana  2   4 , Moses R Kamya  1   2 , Jessica Briggs  3
Affiliations

Seroprevalence of SARS-CoV-2 and risk factors for infection among children in Uganda: a serial cross-sectional study

Irene Bagala et al. medRxiv. .

Update in

Abstract

Background: Understanding COVID-19's impact on children is vital for public health policy, yet age-specific data is scarce, especially in Uganda. This study examines SARS-CoV-2 seroprevalence and risk factors among Ugandan children at two timepoints, along with COVID-19-related knowledge and practices in households, including adult vaccination status.

Methods: Baseline surveys were conducted in 12 communities from April to May 2021 (post-Alpha wave) and follow-up surveys in 32 communities from November 2021 to March 2022 (Omicron wave). Household questionnaires and blood samples were collected to test for malaria by microscopy and for SARS-CoV-2 using a Luminex assay. Seroprevalence was estimated at both the survey and community level. Mixed-effects logistic regression models assessed the association between individual and household factors and SARS-CoV-2 seropositivity in children, adjusting for household clustering.

Results: More households reported disruptions in daily life at baseline compared to follow-up, though economic impacts lingered. By the follow-up survey, 52.7% of adults had received at least one COVID-19 vaccine dose. Overall seroprevalence in children was higher at follow-up compared to baseline (71.6% versus 19.2%, p < 0.001). Seroprevalence in children ranged across communities from 6-37% at baseline and 50-90% at follow-up. At baseline, children from the poorest households were more likely to be infected. Increasing age remained the only consistent risk factor for SARS-CoV-2 seroconversion at both timepoints.

Conclusions: Results indicate that a larger number of children were infected by the Delta and Omicron waves of COVID-19 compared to the Alpha wave. This study is the largest seroprevalence survey in children in Uganda, providing evidence that most children were infected with SARS-CoV-2 before the vaccine was widely available to pediatric populations. Pediatric infections were vastly underreported by case counts, highlighting the importance of seroprevalence surveys in assessing disease burden when testing and reporting rates are limited and many cases are mild or asymptomatic.

Keywords: COVID-19; COVID-19 risk factors in children; COVID-19 vaccination; SARS-CoV-2; seroprevalence; serosurvey.

PubMed Disclaimer

Conflict of interest statement

Competing Interest Declaration The authors have no competing interests.

Figures

Figure 1:
Figure 1:
Study profile of participants enrolled in the study
Figure 2.
Figure 2.
Timing of the baseline (blue) and follow-up (green) cross-sectional surveys.
Figure 3.
Figure 3.. SARS-CoV-2 seroprevalence in the target areas surrounding MRCs in the baseline and follow-up cross-sectional surveys.
A. RBD seroprevalence in children ages 2–10 in the baseline survey. B. RBD seroprevalence in children 0–17 in the follow-up survey.
See this image and copyright information in PMC

References

    1. World Health Organization. Coronavirus (COVID-19) Dashboard, Uganda [Internet]. [cited 2024 Mar 14]. Available from: https://covid19.who.int/region/afro/country/ug
    1. Namuganga JF, Briggs J, Roh ME, Okiring J, Kisambira Y, Sserwanga A, et al. Impact of COVID-19 on routine malaria indicators in rural Uganda: an interrupted time series analysis. Malar J. 2021. Dec 20;20(1):1–11. - PMC - PubMed
    1. Massinga Loembé M, Tshangela A, Salyer SJ, Varma JK, Ouma AEO, Nkengasong JN. COVID-19 in Africa: the spread and response. Nat Med. 2020. Jul;26(7):999–1003. - PubMed
    1. Salyer SJ, Maeda J, Sembuche S, Kebede Y, Tshangela A, Moussif M, et al. The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study. Lancet. 2021;397(10281):1265. - PMC - PubMed
    1. Bamgboye EL, Omiye JA, Afolaranmi OJ, Davids MR, Tannor EK, Wadee S, et al. COVID-19 Pandemic: Is Africa Different? J Natl Med Assoc. 2021. Jun;113(3):324–35. - PMC - PubMed

Publication types

LinkOut - more resources